Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernesto Rossi

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Oncotarget|March 2, 2018
Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urotheliumGiovanni Schinzari, Ernesto Rossi, Francesco Pierconti, et al.
Cancers|July 26, 2020
"To Anticipate": Neoadjuvant Therapy in Melanoma with a Focus on Predictive BiomarkersMattia Garutti, Silvia Buriolla, Elisa Bertoli, et al.
Cancers|November 27, 2021
Uveal Melanoma MetastasisErnesto Rossi, Michela Croce, Francesco Reggiani, et al.
Frontiers in Immunology|May 27, 2024
Prognostic role of circulating cytokines and inflammation indexes for avelumab maintenance in metastatic urothelial carcinomaBrigida Anna Maiorano, Giovanni Schinzari, Carmine Carbone, et al.
Critical Reviews in Oncology/Hematology|May 22, 2019
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisionsRoberto Iacovelli, Chiara Ciccarese, Giovanni Schinzari, et al.
Plos One|March 25, 2021
Clinical and ultrasonographic features of choroidal metastases based on primary cancer site: Long-term experience in a single centerMaria Antonietta Blasi, Martina Maceroni, Carmela Grazia Caputo, et al.
Anticancer Research|October 25, 2017
Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin FeasibilityGiovanni Schinzari, Santa Monterisi, Francesco Pierconti, et al.
International Journal of Molecular Sciences|November 6, 2019
Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of MelanomaErnesto Rossi, Giovanni Schinzari, Brigida Anna Maiorano, et al.
Current Oncology Reports|November 8, 2021
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?Ernesto Rossi, Melissa Bersanelli, Alain Jonathan Gelibter, et al.
Urologic Oncology|December 14, 2021
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinomaFrancesco Pierconti, Maurizio Martini, Tonia Cenci, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Oncotarget|March 2, 2018
Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urotheliumGiovanni Schinzari, Ernesto Rossi, Francesco Pierconti, et al.
Cancers|July 26, 2020
"To Anticipate": Neoadjuvant Therapy in Melanoma with a Focus on Predictive BiomarkersMattia Garutti, Silvia Buriolla, Elisa Bertoli, et al.
Cancers|November 27, 2021
Uveal Melanoma MetastasisErnesto Rossi, Michela Croce, Francesco Reggiani, et al.
Frontiers in Immunology|May 27, 2024
Prognostic role of circulating cytokines and inflammation indexes for avelumab maintenance in metastatic urothelial carcinomaBrigida Anna Maiorano, Giovanni Schinzari, Carmine Carbone, et al.
Critical Reviews in Oncology/Hematology|May 22, 2019
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisionsRoberto Iacovelli, Chiara Ciccarese, Giovanni Schinzari, et al.
Plos One|March 25, 2021
Clinical and ultrasonographic features of choroidal metastases based on primary cancer site: Long-term experience in a single centerMaria Antonietta Blasi, Martina Maceroni, Carmela Grazia Caputo, et al.
Anticancer Research|October 25, 2017
Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin FeasibilityGiovanni Schinzari, Santa Monterisi, Francesco Pierconti, et al.
International Journal of Molecular Sciences|November 6, 2019
Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of MelanomaErnesto Rossi, Giovanni Schinzari, Brigida Anna Maiorano, et al.
Current Oncology Reports|November 8, 2021
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?Ernesto Rossi, Melissa Bersanelli, Alain Jonathan Gelibter, et al.
Urologic Oncology|December 14, 2021
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinomaFrancesco Pierconti, Maurizio Martini, Tonia Cenci, et al.
Pageof 9